Feature | ASTRO | October 08, 2018

ASTRO 2018 Radiation Therapy Clinical Trials

ASTRO 2018 Radiation Therapy Clinical Trials

October 8, 2018 — The American Society for Radiation Oncology (ASTRO) announced the 10 top-rated clinical studies that will be highlighted in the press program for the ASTRO 2018 annual meeting, Oct. 21-23 at the Henry B. Gonzalez Convention Center in San Antonio, Texas. ASTRO’S Annual Meeting is the premier radiation oncology scientific event in the world and draws more than 11,000 attendees each year. 

The scientific program brings together clinicians, scientists and researchers from all oncology disciplines to exchange ideas, promote multidisciplinary care, and address the educational and professional development interests of attendees. Scientific and educational sessions will cover specific clinical areas including breast, central nervous system, gastrointestinal, genitourinary, gynecologic, head and neck, immunotherapy, lymphoma, musculoskeletal, pediatric, sarcoma and thoracic cancers.

The briefing schedule is as follows:

Advances in Breast and Lung Cancers

Sunday, Oct. 21

  • "Randomized Trial Evaluating Radiation following Surgical Excision for 'Good Risk' DCIS: 12-Year Report from NRG/RTOG 9804," presented by Beryl McCormick, Memorial Sloan Kettering Cancer Center (Abstract LBA-1)
  • "FAST Phase III RCT of Radiation Therapy Hypofractionation for Treatment of Early Breast Cancer: 10-Year Results (CRUKE/04/015)," presented by Murray Brunt, Institute of Cancer Research, London (Abstract LBA-2)
  • "Local Consolidative Therapy (LCT) Improves Overall Survival (OS) Compared to Maintenance Therapy/Observation in Oligometastatic Non-Small Cell Lung Cancer (NSCLC): Final Results of a Multicenter, Randomized, Controlled Phase 2 Trial," presented by Daniel Gomez, University of Texas MD Anderson Cancer Center (Abstract LBA-3)


Advances in Genitourinary Cancers

Monday, Oct. 22

  • "Androgen Receptor Activity and Radiotherapeutic Sensitivity in African-American Men with Prostate Cancer: A Large-Scale Gene Expression Analysis and Meta-analysis of RTOG Trials," presented by Daniel Spratt, University of Michigan (Abstract 4)
  • "Long-Term Outcomes of Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Adenocarcinoma: A Multi-Institutional Consortium Study," presented by Amar U. Kishan, University of California, Los Angeles (Abstract 217)
  • "Renal SABR in Patients with a Solitary Kidney: An Individual-Patient Pooled Analysis from the International Radiosurgery Oncology Consortium for Kidney (IROCK)," presented by Rohann Correa, London Regional Cancer Program (Abstract 222)
  • "Short Term Androgen Deprivation Therapy Without or With Pelvic Lymph Node Treatment Added to Prostate Bed Only Salvage Radiation Therapy: The NRG Oncology/RTOG 0534 SPPORT Trial," presented by Alan Pollack, University of Miami (Abstract LBA-5)


Advances in Oral and Oligometastatic Cancers

Tuesday, Oct. 23

  • "Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Tumors (SABR-COMET): Results of A Randomized Trial," presented by David Palma, London Health Sciences Centre (Abstract 5)
  • "NRG-RTOG 1016: Phase III Trial Comparing Radiation/Cetuximab to Radiation/Cisplatin in HPV-related Cancer of the Oropharynx," presented by Andy Trotti, Moffitt Cancer Center (Abstract LBA-4)
  • "Plasma Circulating Tumor HPV DNA for the Surveillance of Cancer Recurrence in HPV-associated Oropharyngeal Cancer," presented by Bhisham Chera, University of North Carolina (Abstract LBA-6)

For more information: www.astro.org

Related Content

Videos | Image Guided Radiation Therapy (IGRT) | October 15, 2018
Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute, describes the benefits the departm
Varian Expands Cancer Care Portfolio With Noona Healthcare Acquisition
News | Patient Engagement | October 15, 2018
Varian announced the acquisition of privately-held software company Noona Healthcare, developer of a cloud-based,...

Images from computed tomography (CT) colonography show segmented abdominal aortic calcification measured with semiautomated CT tool on coronal image. Within region of interest over aorta selected by user, tool automatically segments and quantifies aortic calcification (shown in blue). 

Image Credit: O’Connor S D, Graffy P M, Zea R, et al. Does nonenhanced CT-based quantification of abdominal aortic calcification outperform the Framingham Risk Score in predicting cardiovascular event sin asymptomatic adults? Radiology doi: 10.1148/radiol.2018180562. Published online Oct. 2, 2018. © RSNA.

News | Computed Tomography (CT) | October 12, 2018
Computed tomography (CT)-based measures of calcification in the abdominal aorta are strong predictors of heart attacks...
New Guideline for Prostate Cancer Supports Shortened Radiation Therapy
News | Prostate Cancer | October 12, 2018
Three prominent medical societies issued a new clinical guideline for physicians treating men with early-stage prostate...
iCAD Announces Positive Clinical Results for Artificial Intelligence Tomosynthesis Technology
News | Mammography | October 11, 2018
iCAD Inc. announced positive clinical results of its new digital breast tomosynthesis (DBT) cancer detection software,...
Surgery, Radiation Therapy Equally Effective in Treating Oropharyngeal Cancer
News | Radiation Therapy | October 09, 2018
A new study by researchers at UT Southwestern Medical Center found no major long-term differences in the effectiveness...
Videos | Treatment Planning | October 08, 2018
Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology at Henry Ford Health System, descri
ViewRay and Miami Cancer Institute Host Symposium on MR-Guided Radiation Therapy
News | Image Guided Radiation Therapy (IGRT) | October 05, 2018
October 5, 2018 — Leading oncology experts from around the world recently met to discuss the integration of...
Videos | Treatment Planning | October 05, 2018
Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology at Henry Ford Health System, descri
Videos | Image Guided Radiation Therapy (IGRT) | October 04, 2018
Carrie Glide-Hurst, Ph.D., and Benjamin Movsas, M.D., discuss Henry Ford Hospital's involvement in a national clinica